Judge Temporarily Blocks Texas Smokeable Hemp Ban
The temporary block on Texas hemp smokeable products ban creates uncertainty for patients relying on these products. This ruling affects legal access and regulatory clarity in Texas. Clinicians must stay informed about evolving hemp product regulations.
Salus at Drexel University Hosts Continuing Education on Medical Cannabis
The continuing education medical cannabis event at Drexel University aims to improve clinician understanding of cannabis pharmacology. This program focuses on the endocannabinoid system and its therapeutic relevance. Physicians will gain essential…
How Much Terpene Spray Should You Use? Insights & Guidance
Terpene dosing guidance remains largely empirical but is crucial for safe symptom management. Patients often ask how much terpene spray to use for best results. This article offers practical advice on terpene dosing guidance to help clinicians counsel…
Amyotrophic Lateral Sclerosis (ALS) and Medical Cannabis in Utah
Utah's amyotrophic lateral sclerosis cannabis guidelines provide a state-sanctioned framework for managing ALS symptoms with medical cannabis. These guidelines influence patient access and prescribing protocols. They represent growing recognition of…
Cannabis for Symptom Relief in HIV and Cancer: A Map of What We Know—and What We Don’t
Cannabis symptom management HIV cancer is an emerging field with limited but growing observational evidence. This review highlights gaps in dosing, safety, and effectiveness data. Patients and clinicians face uncertainty while seeking symptom relief…
Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.
This study examines demographics cannabis use cancer patients, focusing on reasons, methods, and perceived benefits. Nearly 25% of surveyed cancer patients reported cannabis use. The findings provide insight into patient behaviors and symptom management.
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
This study explores cannabis stigma symptom management among cancer survivors. It assesses patient attitudes and perceptions regarding cannabis use for symptom relief. Findings reveal generally positive views and minimal stigma from healthcare providers.
Understanding Cannabis Use for Symptom Management in Cancer Patients
Cannabis use cancer symptom management is increasingly common among patients undergoing treatment. The National Cancer Institute supports studies to evaluate both benefits and harms. These efforts aim to provide rigorous data to guide clinical…
Are You Eligible to Book a Medical Cannabis Appointment?
Understanding medical cannabis eligibility is key to accessing treatment. At CED Clinic, we help you determine if you qualify for medical cannabis. Booking an appointment is simple and personalized to your needs.